6JUNE - 2023TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe European pharma industry is witnessing a rapid transformation due to technological advancements. With increasing demand for personalized medicine, rare disease treatments, and biosimilars, they are looking for contract manufacturing partners with specialized capabilities and expertise. The contract manufacturing organizations (CMOs) are adopting digital technologies to improve their processes, increase efficiency, and deliver high-quality products.One of the significant technology trends in the European pharma industry's contract manufacturing arena is the use of automation and robotics as they allow for greater precision and efficiency, resulting in faster turnaround times and increased production volumes. Moreover, CMOs are leveraging cloud-based platforms to enable real-time tracking of inventory, procurement, and logistics. This significantly improves visibility into supplier performance, enabling CMOs to optimize supplier relationships and reduce supply chain risks for their clients. These trends in contract manufacturing organizations reflect the industry's continued evolution towards more specialized and highly regulated products. Today, the European pharma industry is open to embracing digital technologies to deliver high-quality products, improve efficiency, and reduce costs. This makes CMOs that are well-positioned to meet these changing needs critical for pharma firms looking to develop and deliver transformative medical devices and pharmaceuticals.In this edition of Pharma Tech Outlook Europe, we bring the story of some of the top contract manufacturing organization delivering the best outcomes for their clients. This issue features innovative companies like Adragos Pharma, specializing in the production of finished dosage forms (FDF) in the small-molecule segment by minimizing lead times and offering exceptional flexibility. We hope this edition will provide you with the right assistance in choosing the CMO that fit your business requirements.A Tech-Driven Revolution of the European Pharma IndustryCopyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JUNE - 12 - 2023, Vol 09 - Issue 06 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerRonald DonovanEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul Barbersales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Parley MeadowTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >